Original news and analysis on international IP policy
The joint United Nations Programme on HIV/AIDS (UNAIDS) today praised the commitment made by India's Commerce Minister not to negotiate stronger intellectual property rights provisions that could undermine India's global leadership in the production of affordable generic AIDS drugs.
A diverse team of global experts on public health research and development will meet this week behind closed doors to analyse proposals for ways to fund R&D on diseases afflicting poor populations – and for who should coordinate such global efforts.
A Canadian bill to improve global access to medicines might get another shot in the new Parliament, writes Daniele Dionisio.
For the past ten years, the United States Supreme Court has steadily chipped away at patent rights. But this term, the court abruptly reversed direction. In two weeks, the high court issued rulings in three patent cases, and in every one upheld the legal rights of inventors. It is unclear, however, how big a win this really was for patent rights.
The US House of Representatives this evening passed HR 1249 – the closest action patent reform has come to being enacted into law in the past 10 years. But there were some changes made to the bill.
The head of Geneva-based UNITAID, an innovative drug purchasing system for the global poor, will leave the post this month.
At the last session of the World Trade Organization Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council, the Dominican Republic challenged an Australian draft law requiring plain packaging for tobacco products as being incompatible with its WTO obligations, eclipsing other agenda items. The TRIPS Council also addressed other regular agenda items such as related to biodiversity and public health, according to sources.
NEW YORK - The declaration from the United Nations High-Level Meeting on AIDS, which concluded today, set targets for responding to the disease and contained clear references to flexibilities to intellectual property law intended to assure needed medicines can be obtained affordably, according to Brazil's health minister.
Pharmaceutical manufacturer Merck will donate its entire library of natural products to the Institute for Hepatitis and Virus Research along with a grant, the institute announced this week. The library, one of the world's largest, will be open for researchers around the world.
This week the United Nations meets in New York with the possibility of finding a way to end the HIV crisis that in the past two decades spread like wildfire and decimated societies in many developing countries, in particular in sub-Saharan Africa.
The Drugs for Neglected Diseases initiative (DNDi) signed an agreement with pharmaceutical manufacturer Sanofi on 30 May for a three-year research project on nine neglected tropical diseases that will come with intellectual property rights on research results for both sides, according to a press release from the international organisation in Switzerland.
The European Commission has issued a new draft customs regulation that it says addresses past concerns over wrongful seizures of generic drug shipments transiting through European ports. But the new regulation does not substantively change existing rules, it said, and civil society groups say it does not go far enough. The EU regulation is the subject of a World Trade Organization dispute settlement case.